267 related articles for article (PubMed ID: 20697746)
21. Prophylaxis of radiation-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
Li WS; van der Velden JM; Ganesh V; Vuong S; Raman S; Popovic M; Lam H; Wong KH; Ngan RK; Burbach JPM; DeAngelis C; Xxxx RM; Chow E
Ann Palliat Med; 2017 Apr; 6(2):104-117. PubMed ID: 28249542
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy-induced nausea and vomiting.
Dennis K; Maranzano E; De Angelis C; Holden L; Wong S; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):685-92. PubMed ID: 22098284
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
Chow R; Tsao M; Chiu L; Popovic M; Milakovic M; Lam H; DeAngelis C
Ann Palliat Med; 2018 Apr; 7(2):221-233. PubMed ID: 29764184
[TBL] [Abstract][Full Text] [Related]
24. Radiation-induced emesis: a problem with many open questions.
Maranzano E
Tumori; 2001; 87(4):213-8. PubMed ID: 11693797
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting?
Horiot JC
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1018-25. PubMed ID: 15519770
[TBL] [Abstract][Full Text] [Related]
26. [Perceptual gap between oncologists/oncology nurses and patients in the management and impact of chemotherapy/radiotherapy-induced nausea and vomiting: French results of the GAP survey].
Morin S; Leurs I; Bousquet MN; Scotté F
Bull Cancer; 2016 May; 103(5):469-77. PubMed ID: 27015797
[TBL] [Abstract][Full Text] [Related]
27. Latest advances in the management of radiation-induced pain flare, nausea and vomiting.
Chiu N; Chiu L; Popovic M; DeAngelis C; Pasetka M; Lutz S; Zhang N; Marta GN; Mendez LC; Lechner B; Pulenzas N; Milakovic M; Chow R; Chow E
Ann Palliat Med; 2016 Jan; 5(1):50-7. PubMed ID: 26841815
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):619-25. PubMed ID: 10348292
[TBL] [Abstract][Full Text] [Related]
29. Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting.
Burmeister H; Aebi S; Studer C; Fey MF; Gautschi O
Support Care Cancer; 2012 Jan; 20(1):141-7. PubMed ID: 21234609
[TBL] [Abstract][Full Text] [Related]
30. An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting.
Fabi A; Malaguti P
Expert Opin Pharmacother; 2013 Apr; 14(5):629-41. PubMed ID: 23414148
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT).
Ades S; Halyard M; Wilson K; Ashikaga T; Heimann R; Kumar S; Blackstock W
Support Care Cancer; 2017 May; 25(5):1503-1510. PubMed ID: 28032216
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study.
De Tursi M; Carella C; Tomao S; Cinieri S; Lorusso V; Marchetti P; Vecchio S; Sansoni E; Contu A; Adamo V; Silvestris N; Nuzzo A; Rosti G; Ravaioli A; Danova M; Tonini G; Passalacqua R; Cruciani G; Faedi M; Spada M; De Laurentiis M; Amoroso D; Tomao F; Sperduti I; Grassadonia A; Tinari N; Natoli C; Iacobelli S;
Tumori; 2014; 100(6):e309-13. PubMed ID: 25688518
[TBL] [Abstract][Full Text] [Related]
33. Possible role of aprepitant for intractable nausea and vomiting following whole brain radiotherapy-a case report.
Ahuja D; Bharati SJ; Gupta N; Kumar R; Bhatnagar S
Ann Palliat Med; 2016 Oct; 5(4):315-318. PubMed ID: 27701875
[TBL] [Abstract][Full Text] [Related]
34. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
Natale JJ
Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
[TBL] [Abstract][Full Text] [Related]
35. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
[TBL] [Abstract][Full Text] [Related]
36. 2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.
Einhorn LH; Rapoport B; Navari RM; Herrstedt J; Brames MJ
Support Care Cancer; 2017 Jan; 25(1):303-308. PubMed ID: 27815710
[TBL] [Abstract][Full Text] [Related]
37. MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patients.
Affronti ML; Lee J; Molassiotis A; Johnson L; Tinianov S; Clark-Snow R; Scotte F
Support Care Cancer; 2024 May; 32(6):335. PubMed ID: 38727834
[TBL] [Abstract][Full Text] [Related]
38. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
Herrstedt J
Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
[TBL] [Abstract][Full Text] [Related]
39. [Chemotherapy-induced nausea and vomiting : Current recommendations for prophylaxis].
Storz E; Gschwend JE; Retz M
Urologe A; 2018 May; 57(5):532-542. PubMed ID: 29589051
[TBL] [Abstract][Full Text] [Related]
40. International radiation oncology trainee decision making in the management of radiotherapy-induced nausea and vomiting.
Dennis K; Zhang L; Lutz S; van der Linden Y; van Baardwijk A; Holt T; Lagrange JL; Foro-Arnalot P; Wong LC; Maranzano E; Wong KH; Liu R; Vassiliou V; Corn BW; De Angelis C; Holden L; Wong CS; Chow E
Support Care Cancer; 2013 Jul; 21(7):2041-8. PubMed ID: 23440546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
